Results 271 to 280 of about 347,248 (305)

Toll-like Receptor 4 Signaling Promotes Tumor Growth

Journal of Immunotherapy, 2010
Chronic inflammation is a potential risk factor for tumor progression. The molecular mechanisms linking chronic inflammation and tumor growth have proven elusive. Herein, we describe a new role for Toll-like receptor 4 (TLR4) in tumor-associated macrophages (TAMs) in promoting tumor growth.
Che-Hsin, Lee, Chao-Liang, Wu, Ai-Li, Shiau   +2 more
openaire   +2 more sources

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Nature Medicine, 2007
L. Apetoh, F. Ghiringhelli, A. Tesnière, A. Tesnière, A. Tesnière, Michel Obeid, Michel Obeid, Michel Obeid, Carla Ortiz, Carla Ortiz, Carla Ortiz, A. Criollo, A. Criollo, A. Criollo, G. Mignot, G. Mignot, G. Mignot, M. Maiuri, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, P. Saulnier, Huan Yang, S. Amigorena, B. Ryffel, F. Barrat, P. Saftig, Francis Lévi, Francis Lévi, R. Lidereau, C. Noguès, J. Mira, A. Chompret, V. Joulin, F. Clavel-Chapelon, J. Bourhis, F. André, S. Delaloge, T. Tursz, Guido Kroemer, Guido Kroemer, Guido Kroemer, L. Zitvogel   +42 more
semanticscholar   +1 more source

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

Nature Medicine, 2007
T. Vogl, K. Tenbrock, S. Ludwig, Nadja Leukert, C. Ehrhardt, M. V. Zoelen, W. Nacken, D. Foell, T. Poll, C. Sorg, J. Roth   +10 more
semanticscholar   +1 more source

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

Nature, 2001
K. Fitzgerald, E. Palsson-McDermott, A. Bowie, C. Jefferies, A. Mansell, G. Brady, E. Brint, A. Dunne, Pearl Gray, M. Harte, D. McMurray, Dirk E. Smith, J. Sims, T. Bird, L. O’Neill   +14 more
semanticscholar   +1 more source

TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway

Nature Immunology, 2003
Masahiro Yamamoto, Shintaro Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, S. Akira   +8 more
semanticscholar   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly